Annual 2014 Symposium of the AHA Basic Cardiovascular Sciences Council

描述（由申请人提供）： 这是美国心脏协会基础心血管科学理事会2014年夏季年度研讨会的新申请。 这次会议在过去的9年里得到了NHLBI的持续支持，这次会议将是10周年纪念会议。 来自NHLBI的支持帮助促成了一次会议，该会议已成为处理分子心血管生物学和疾病的“去”会议。 它代表其赞助商，美国心脏协会基础心血管科学（BCVS）理事会，这是世界领先的心血管科学家组织。 这个会议最初开始于二十年前，当时理事会在1991年举行了一次分子心脏病学会议，然后举行了几次会议，最初被称为雪鸟会议，因为它是在夏天在犹他州的雪鸟举行的。 该会议于2002年成为年度活动，自2004年以来，该会议已被公认为AHA的永久性，经常性的科学会议，R13资金也开始。 近年来的会议已经开始混合在翻译的主题以及这个会议的“面包和黄油”，这是基础分子心血管研究。 该会议一直吸引着microRNA、心脏基因和细胞治疗、心脏发育以及最近的组织工程和iPS细胞等领域的领先研究人员。 这个会议的出席人数每年都在攀升，2013年我们有超过550人的历史最高出席人数。 与往年一样，会议将于7月在拉斯维加斯举行。 会议将在巴黎酒店举行，会议空间在巴黎拉斯维加斯会议中心。 计划的议程代表了一个雄心勃勃的，快节奏的会议，在4天（2014年7月14日至17日）的12个会议，其中两个会议是主题演讲。 今年的主题演讲计划由海伦·霍布斯博士和彼得·雷迪恩博士主讲。 年轻的心血管科学家也将通过每场会议的特邀演讲得到强调，海报将在会议的3天内展示。 这次会议的组织者是伯恩斯·布拉克索尔博士（辛辛那提儿童医院）、朱陈（加州大学圣地亚哥分校）和约瑟夫·吴（斯坦福大学）。 提案申请约占会议总预算的7%，由于我们在过去几年中有所下降，因此该申请的支持将用于心血管外展奖（少数民族旅行奖）和新研究者旅行奖。

DESCRIPTION (provided by applicant): This is a new application for the Annual Summer 2014 Symposium of the Basic Cardiovascular Sciences Council of the American Heart Association. This conference has had continuous support from the NHLBI for the last 9 years and this will be the 10th Anniversary meeting. Support from the NHLBI has helped foster a meeting that has become the "go to" conference dealing with molecular cardiovascular biology and disease. It represents its sponsor, the Basic Cardiovascular Sciences (BCVS) Council of the American Heart Association, which is the world's leading organization of cardiovascular scientists. Ths conference started originally two decades ago as the Council held a Molecular Cardiology conference in 1991 and then had several meetings initially hailed as the Snowbird Conference as it was held during the summer at Snowbird, Utah. The meeting became an annual event in 2002 and since 2004 this conference has been recognized as a permanent, recurring scientific meeting of the AHA and R13 funding also commenced. The conference in recent years has begun to mix in translational topics as well as the "bread and butter" of this meeting, which is basic molecular cardiovascular research. The conference has always attracted the leading researchers in fields such as microRNAs, cardiac gene and cell therapy, cardiac development and most recently, tissue engineering and iPS cells. The attendance of this conference has climbed every year and in 2013 we had an all-time high attendance of over 550. As in past years, the conference will be held in July and will be in Las Vegas. The meeting will be held in the Paris Hotel with meeting space in the Paris Las Vegas Conference Center. The planned agenda represents an ambitious, fast-paced meeting with 12 sessions over 4 days (July 14-17, 2014) with two of these sessions being Keynote lectures. This year's Keynote lectures have been planned with Drs. Helen Hobbs and Peter Reddien being the speakers. Young cardiovascular scientists will be highlighted as well through invited talks in each session and Posters will be presented on 3 days of the conference. Organizers of this meeting are Drs. Burns Blaxall (Cincinnati Children's Hospital), Ju Chen (UCSD) and Joseph Wu (Stanford). The proposal request constitutes approximately 7% of the total meeting budget and as we have down over the last several years, support from this application will be used toward Cardiovascular Outreach Awards (minority travel awards) and New Investigator Travel Awards.